The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMediumUpdated•Originally published 31 March 2026•Updated 31 March 2026•

1 min read

BioHarvest Sciences Reports 37% Revenue Growth in 2025 as Losses Narrow

Key Facts

1BioHarvest recorded full-year 2025 revenue of $34.5 million, a 37% increase over the previous year.

2Financial results showed margin expansion and a narrowing of net losses.

4 months ago

Version History

2 additional sources confirmed this story

Version 14 months ago

What changed: Added specific Q4 earnings-per-share (EPS) data showing a beat against analyst estimates and year-over-year improvement, while noting a miss on quarterly revenue estimates.

BioHarvest Sciences Inc. (NASDAQ: BHST) reported full-year 2025 revenue of $34.5 million, marking a 37% increase over the previous year. In the fourth quarter, the company posted a loss of $0.10 per share, outperforming the Zacks Consensus Estimate of a $0.11 loss. This performance reflects a significant year-over-year improvement from the $0.17 loss per share recorded in the same period last year. While quarterly revenue figures lagged behind analyst expectations, the company's overall trajectory remains focused on narrowing net losses through improved operational efficiency. Strategic investments in core product segments and contract manufacturing continue to drive margin expansion. Management highlighted that these results underscore the company's progress toward achieving sustainable profitability in the biotech sector.